Skip to main content
. 2018 Jul 12;2(2):pky028. doi: 10.1093/jncics/pky028

Figure 1.

Figure 1.

A patient flow chart for association of metabolic, inflammatory, and tumor markers with circulating tumor cells in metastatic breast cancer—a cross-sectional study. *Insufficient blood or technical problems due to ferrofluid aggregation or blood clot. **Nine patients excluded after charts were reviewed (three did not have evidence of breast cancer progression, three did not have metastatic breast cancer, one had diabetes, and two received prednisone before the study visit).